Monday, January 4, 2021

Controversy around Bharat Biotech's Covaxin approval without efficacy data

Bharat Biotech's Covaxin is based on a whole inactivated virus platform, an old technology which is used to make vaccines given to infants

from Latest News https://ift.tt/2Mult6e
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

Related Posts:

0 comments: